Skelaxin Pay-For-Delay Battle Heads To Pa. State Court
The latest front in the ongoing antitrust dispute over the muscle relaxant Skelaxin opened in Pennsylvania state court Monday as the head of SigmaPharm Inc. accused a Pfizer unit of conspiring...To view the full article, register now.
Already a subscriber? Click here to view full article